Clinical Trial Update: Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study [Phase 2]

View source ↗

Summary

Phase II clinical trial update exploring pediatric-type therapy with pre-transplant blinatumomab for high-risk Philadelphia-negative acute lymphoblastic leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia-negative Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Israeli Medical Association | Conditions: Philadelphia-Negative ALL, High-Risk Cancer | Phase 2 | Status: UNKNOWN